Literature DB >> 23841200

Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency.

E R Burka, Z Weaver, P A Marks.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 23841200     DOI： 10.7326/0003-4819-64-4-817

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

1.  Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.

Authors:  B O Onadeko; O Bademosi
Journal:  Ir J Med Sci       Date:  1974-07       Impact factor: 1.568

2.  Post-anaesthetic jaundice due to glucose-6-phosphate dehydrogenase deficiency.

Authors:  J M Shapley; J R Wilson
Journal:  Can Anaesth Soc J       Date:  1973-05

3.  [On 2 new cases of hereditary nonspherocytic hemolytic anemia associated with glucose-6-phosphate-dehydrogenase deficiency in a North-German family. I].

Authors:  J Weinreich; D Busch; U Gottstein; J Schaefer; J Rohr
Journal:  Klin Wochenschr       Date:  1968-02-01

4.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

Review 5.  Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.

Authors:  Ali R Elyassi; Henry H Rowshan
Journal:  Anesth Prog       Date:  2009

Review 6.  Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks.

Authors:  R O Francis; J S Jhang; H P Pham; E A Hod; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2013-07-02       Impact factor: 2.144

7.  Aspects of sickle cell gene in Saudi Arabia--interaction with glucose-6-phosphate dehydrogenase deficiency.

Authors:  M A el-Hazmi; A S Warsy
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 8.  Avoidance and management of adverse reactions to antituberculosis drugs.

Authors:  A M Patel; J McKeon
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

Review 9.  Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?

Authors:  Jianle Li; Yicong Chen; Zilin Ou; Fubing Ouyang; Jiahui Liang; Zimu Jiang; Chunyong Chen; Pingping Li; Jiaxin Chen; Jiating Wei; Jinsheng Zeng
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-14       Impact factor: 3.571

Review 10.  G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.

Authors:  Lucio Luzzatto; Elisa Seneca
Journal:  Br J Haematol       Date:  2013-12-28       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.